Improvement of diagnosis and treatment of cerebrovascular complications and premorbid conditions of arterial hypertension in patients with chronic cerebral ischemia
ARTICLE PDF (Українська)

Keywords

chronic cerebral ischemia, dyscirculatory encephalopathy, MMSE scale, DASS-21 scale, medication correction

How to Cite

Cherniy, T. V. (2018). Improvement of diagnosis and treatment of cerebrovascular complications and premorbid conditions of arterial hypertension in patients with chronic cerebral ischemia. Clinical and Preventive Medicine, (2-3), 50-62. https://doi.org/10.31612/2616-4868.2-5.2018.06

Abstract

This article presents the results of one of the parts of the scientific research: "Hypertensive and non-hypertonic (atherosclerotic) dyscirculatory encephalopathy in civil servants.Studied pathogenetic mechanisms of occurrence, integral diagnostic criteria, individualized correction of medical therapy". The data of general clinical examination of 88 persons with chronic cerebral ischemia (dyscirculatory encephalopathy (DE)) of 2 degrees are presented.The first study group - patients with DE without concomitant hypertension - 28, the second - 39 people with hypertonic dyscirculatory encephalopathy (HDE), the third - 21 patients with dyscirculatory encephalopathy and history of stroke (HDE + INS). The purpose of this study was to develop a method for targeted drug correction of cognitive impairment in chronic brain ischemia. The diagnosis was confirmed by general clinical, clinical-neurological, laboratory, instrumental examination, neuropsychological examination (MMSE, DASS-21). In addition to the protocol, patients with dyscirculatory encephalopathy of all the study groups received a complex of drugs aimed at correcting neurotransmitter metabolism: in the morning 1 ml (15 mg) solution of ipidacrine hydrochloride monohydrate (paraplexin) intramuscularly 1 time per day for 14 days. 1-2 hours after administration, ipidacrine was injected sequentially with 4 ml (1000 mg) of choline alfosserate solution and 4 ml (1000 mg) solution of cytocholine intravenously drip 1 time per day for 14 days.

The addition of the protocol for the treatment of patients with dyscirculatory encephalopathy in all the groups studied by a complex of drugs aimed at eliminating cholinergic insufficiency resulted in correction of cognitive impairment in chronic brain ischemia.

Statistically significant manifestations of the recovery of the cognitive function (MMSE scale) after the basic complex of therapy were associated primarily with impulsiveness decrease due to increased attention. Statistically significant manifestations of reduction of anxiety and depressive disorders (on the DASS-21 scale) after the basic complex of therapy were associated primarily with anxiety reduction due to restoration of neurohumoral balance: GABA-ergic inhibitory effects, serotonin-, catecholamine-peptidergic activation systems.

https://doi.org/10.31612/2616-4868.2-5.2018.06
ARTICLE PDF (Українська)

References

1. Belenichev I. F., Cherniy V. I. (2015). Neyroprotektsiya i neyroplastichnost': monografiya[Neuroprotection and neuroplasticity: monograph]. К. : Logos, 512 s.
2. Zhivolupov S. A., Samartsev I. N., Bardakov S. N. (2014). Ratsional'nayaneyroprotektsiya pri travmaticheskoybolezni golovnogo i spinnogo mozga [Rational neuroprotection in traumatic diseases of the brain and spinal cord]. SPb., 128 s.
3. Cherniy V. I., Andronova M. A., Cherniy T. V., Andronova I. A. (2016). Doslidzhennya khronichnoyi ishemiyi mozku za dopomohoyu metodu kilkisnoyi elektroentsefalohrafiyi [Research of chronic cerebral ischemia using the method of quantitative electroencephalography]. Journal of Neurology B. M. Mankovsky, Т. 4, 3, 43-49.
4. Kharchenko Ye. P., Klimenko M. N. (2004). Plastichnost' mozga [Plasticity of the brain]. Chemistry and life XXI century, 6, 26-33.
5. Szuhany Kristin L., Matteo Bugatti, Michael W. Otto. (2014). A meta-analyticreview of the effects ofexerciseon brain-derivedneurotrophic factor. Journal of Psychiatric Research, 60, 56–64.
6. Gomazkov O. A. (2014). Neyrogenez kak adaptivnaya funktsiya mozga [Neurogenesis as an adaptive function of the brain]. Institut biomeditsinskoy khimii imeni V. N. Orekhovicha. Moskva, 85 s.
7. Zhivolupov C. A., Samartsev I. N., Syroyezhkin F. A. (2013). Sovremennaya kontseptsiya neyroplastichnosti (teoreticheskiye aspekty i prakticheskaya znachimost') [ The modern concept of neuroplasticity (theoretical aspects and practical significance)]. Journal of Neurology and Psychiatry, 113, 10, 102-108.
8. Odinak M. M., Zhivolupov S. A., Panomarev V. V., Rashidov N. A., Samartsev I. N. (2014).Vosstanovleniye soznaniya kak proyavleniye neyroplastichnosti [Recovery of consciousness as a manifestation of neuroplasticity]. Neurosurgery Issues, 1, 33-41.
9. Ashmarin I. P., Stukalov P. V. (1996). Neyrokhimiya [Neurochemistry]. M.: Institut biomeditsinskoy khimii RAMN, 469 s.
10. Skoromets A. A. (2005). Neyromediatory pri starenii golovnogo mozga: klyuch k ponimayu narusheniy pamyati i vnimaniya [Neurotransmitters in aging of the brain: the key to understanding memory and attention disorders]. M., 16 s.
11. Vozrastnyye izmeneniya neyrotransmitternykh sistem mozga kak faktor riska tserebrovaskulyarnoy patologii (2013). [Age changes in neurotransmitter brain systems as a risk factor for cerebrovascular pathology]. Journal of neurology B. M. Mankowski, 2, 5-13.
12. Mattson M. P. (2008). Glutamateand neurotrophic factors inneuronal plasticity and disease. Ann N Y AcadSci., 1144, 97-112.
13. Mironova E. V., Evstratova A. A., Antonov S. M. (2007). A fluorescence vital assay for the recognition and quantification of excitotoxic cell death by necrosis and apoptosis using confocal microscopy on neurons in culture. Journal of neuroscience methods, 163, 1, 1-8.
14. Litvinenko I. V. (2008). Osobennosti formirovaniya kognitivnykh narusheniy pri dementsii. Bulletin of the Leningrad State University. A.S. Pushkin. St. Petersburg, 6 (20), 165-175.
15. Litvinenko I. V. (2004). Dementsiya i psikhoticheskiye narusheniya pri parkinsonizme: obshchnost' vozniknoveniya i novyye perspektivy v terapii. The successes of gerontology, 13, 94–101.
16. Ekstrapiramidnyye rasstroystva [Extrapyramidal disorders] (2002) / pod red. V. N. Shtoka, I. A. Ivanovoy-Smolenskoy, O. S. Levina. M., 608.
17. Adibhatla R. M., Hatcher J. F., Dempsey R. J. (2002). Citicoline: Neuroprotective mechanisms in cerebral ischemia. J Neurochem, 80, 12-23.
18. Choline R. I. Precursors in acute and subacute human Stroke: a meta-analisis. Abstracts of 27th International Stroke Conference.
19. D’Orlando K. J., Sandage B. W. (1995). Citicolone (CDP-choline): mechanisms of action and effects In ischemic brain injuri. J. Neurol Res., 17, 281-284.
20. Odinak M. M. Voznyuk I. A., Piradov M. A., Rumyantseva S. A., Kuznetsov A. N., Yanishevskiy S. N., Golokhvastov S. YU., Tsygan N. V. (2010). Mnogotsentrovoye (pilotnoye) issledovaniye effektivnosti gliatilina pri ostromishemicheskom insul'te. Annals of Neurology, 4, 1, 20-27.
21. Amenta F. (2010). Analisicomparativadellasicurezza/efficaciadegliinibitoridellecolinesterasi e del precursorecolinergicocolinaalfosceratonelledemenzeadesordionell’etaadulta. J. Gerontol., 58, 64-6820.
22. Parnetti L., Amenta F., Gallai V. (2001). Choline alphoscerate in cognitive decline and in acute cerebrovascular disease: an analysis of published clinical data. Mechanisms of Ageingand Development, 122, 2041–2055.
23. Murray M. T., Pizzorno J. (2012). The Encyclopedia of Natural Medicine. Third Edition. Simon and Schuster., 12, 32.
24. Saver J. L. (2010). UCLA Stroke Center and Department of Neurology, CA, USA.
25. Di Perri R. (1991). A multicentre trial to evaluate the efficacy and tolerability of a-glyceryl-phosphorylcholinevs Cytidinediphosphocholine in patients with vascular dementia. The Journal of International Medical Research, 19.
26. Weintraub S., Alissa H., Wicklund, David, Salmon P. (2012). The Neuropsychological Profile of Alzheimer Disease. Cold Spring Harbor Perspectives in Medicine, 2(4). a006171. doi: 10.1101/cshperspect.a00617.
27. Tayebati S. K., Nwankwo I. E., Amenta F. (2013). Intranasal drug delivery to the central nervous system: present status and future outlook. Curr. Pharm.Des., 19, 510-26.
28. Burchynskyy S. H. (2002). Preparat Neyromidyn (amirydyn): kliniko-farmakolohichna kharakterystyka ta perspektyvy praktychnoho zastosuvannya [Neuromidin (amiridine): Clinical and pharmacological characteristics and prospects of practical application]. Medicine, 5-6, 37-42.
29. Zhivolupov S. A. (2011). Vliyaniye Neyromidina i tserebrolizina na neyrodinamicheskiye protsessy pri travmaticheskoy bolezni golovnogo mozga [Effect of Neurromidine and Cerebrolysin on Neurodynamic Processes in Traumatic Brain Disease]. Journal of Neurology and Psychiatry, 4, 31–37.
30. Dobrokhotova T. A., Zaytsev O. S., Gogitidze N. V. Primeneniye neyromidina v lechenii bol'nykh s cherepno-mozgovoy travmoy: metodicheskiye rekomendatsii [The use of neuromidine in the treatment of patients with craniocerebral trauma: guidelines]. Moskva, 2005, 12 s.
31. Fedin A. I. (2005). Profilaktika insul'ta [Prevention of stroke]. Neurological messenger, XX-XVII, 1-2, 93-104.
32. Cherniy T. V., Andronova M. A., Cherniy V. I., Andronova I. A. (2017). Issledovaniye EEG-prediktorov neyromediatornoy i neyroglial'noy aktivnosti u bol'nykh s khronicheskoy ishemiyey mezga [EEG predictors of neurotransmitter and neuroglial activity in patients with chronic ischemia of the pulp]. Journal of neurology B.M. Mankovsky, 5, 1, 15-23.
33. Yevtushenko S. K. (2010). Distsirkulyatornaya entsefalopatiya kak anakhronizm otechestvennoy nevrologi [Dyscirculatory encephalopathy as an anachronism of domestic neurologists]. International neurological journal, 36, 6, 22-31.
34. ESH/ESC guide lines for the management of arterial hypertension: the Task Forceforthe Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC) (2013). EurHeart J.,34, 2159–2219.
35. Pro zatverdzhennya ta vprovadzhennya medyko–tekhnolohichnykh dokumentiv zi standartyzatsiyi medychnoyi dopomohy pry arterialniy hipertenziyi: Nakaz MOZ Ukrayiny № 384 vid 24.05.2012 [About the approval and implementation of medical-technological documents on the standardization of medical care for arterial hypertension: the Order of the Ministry of Health of Ukraine No. 384 dated May 24, 2012]. Available at: http://moz.gov.ua/ua/portal/dn_20120524_384.html
36. Shestopalova L. F., Myshchenko T. S., Derevetskaya V. H. (2005). Osoblyvosti kohnityvnykh porushen u khvorykh na dystsyrkulyatornu entsefalopatiyu riznykh stadiy z fibrylyatsiyeyu peredserd [Features of cognitive impairment in patients with dyscirculatory encephalopathy of different stages with atrial fibrillation]. . Ukrainian Journal of Psychoneurology, 13, 2(42), 78-80.
37. Klinichnyy protokol nadannya medychnoyi dopomohy khvorym na dystsyrkulyatornu entsefalopatiyu [Clinical protocol for the provision of medical care to patients with dyscirculatory encephalopathy]. Kod MKKH-10. Dodatok do nakazu MOZ №487 vid 17-08-2007.
38. Mishchenko T. S., Mishchenko V. N., Lapshina I. A. (2015). Optimizatsiya terapii bol'nykh distsirkulyatornoy entsefalopatiyey [Optimization of therapy for patients with discirculatory encephalopathy]. Ukrainian Journal of Psychoneurology, 23, 1(82), 37-41.
39. Mishchenko T. S. (2013). Distsirkulyatorna yaentsefalopatiya: ustarevshiy termin ili klinicheskaya real'nost' [Dysirculatory yaencephalopathy: an outdated term or clinical reality]. International Neurological Journal, 2 (56), 65-77.
40. Yakhno N. N., Zakharov V. V., Lokshina A. B. (2005). Sindrom umerennykh kognitivnykh narusheniy pri distsirkulyatornoy entsefalopatii [Syndrome of moderate cognitive impairment in dyscirculatory encephalopathy]. Journal of neurol. and psychiatrist. S.S. Korsakov, 105, 2, 13-17.
41. Luriya A. R. (2003). Osnovy neyropsikhologii: ucheb. posobiye dlya stud. vyssh. ucheb. Zavedeniy [Fundamentals of Neuropsychology: Textbook. allowance for stud. supreme. training. institutions]. M.: Akademiya, 384.
42. Savchyn M. V., Vasylenko L. P. (2006). Vikova psykholohiya: navchalnyy posibnyk [Age psychology: tutorial]. K.: Akademvydav, 360.
43. Popenya I. S. (2008). Kurs lektsiy po obshchey meditsinskoy psikhologii: posobiye dlya studentov mediko-psikhologicheskogo, lechebnogo, pediatricheskogo i mediko-diagnosticheskogo fakul'tetov [The course of lectures on general medical psychology: a manual for students of the medical-psychological, medical, pediatric and medical-diagnostic faculties]. Grodno: GrGMU, 77.
44. Chuprina S. Ye.(2009). Psikhokorrektsiya v kompleksnom lechenii distsirkulyatornoy entsefalopatii s pogranichnymi psikhicheskimi rasstroystvami [Psychocorrection in the complex treatment of discirculatory encephalopathy with borderline mental disorders]. Moskva, 89.
45. Klinicheskaya psikhologiya (2007) [Clinical Psychology] / red. B.D. Karvasarskiy. SPb: Piter, 960.
46. Sidorov P. I., Parnyakov A. V. (2010). Klinicheskaya psikhologiya [Clinical psychology]. M.: GEOTAR-Media, 880.
47. Orlova Ye. A., Kolesnik N. T. (2014). Klinicheskaya psikhologiya [Clinical psychology]. M.: Yurayt, 368.
48. Bohnen N. I., Mueller M .L., Kuwabara H. (2009). Age-associated leukoaraiosis and cortical cholinergic deafferentation. Neurology, 72, 1411–1416.
49. Serebryakova T. A. (2007). Psikhologiya stressa: uchebnoye posobiye [Psychology of stress: a textbook]. N. Novgorod: VGIPU, 143.
50. Lapin I. P. (1998). Neyrokhimicheskaya mozaika trevogi i individualizatsiya psikhofarmakologii [Neurochemical mosaic of anxiety and individualization of psychopharmacology]. Anxiety and obsessions. M., 12–20.
51. Rachin A. P., Mikhaylova Ye. V. (2016). Depressivnyye i trevozhnyye rasstroystva [Depressive and anxiety disorders]. M.: GEOTAR-Media, 106.
52. Lyakh YU. Ye., Gur'yanov V. G., Khomenko V. N., Panchenko O. A. (2006). Osnovy komp'yuternoy biostatistiki: analiz informatsii v biologii, meditsine i farmatsii statisticheskim paketom MedStst [Fundamentals of computer biostatistics: the analysis of information in biology, medicine and pharmacy statistical package MedStst]. D: Papakitsa Ye.K., 214.
53. Sotnikov P. I. (2014). Obzor metodov obrabotki signala elektroentsefalogrammy vinterfeysakhmozg-komp'ter [Review of methods for processing the signal of the electroencephalogram ininterfaces to the brain-computer]. Engineering Bulletin, 10, 6120-632.
Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.